← SynDRA
REVAPRAZAN
SynDRA canonical compound SYN0025737 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | ATP4A |
|---|
| Mechanism of action | potassium-competitive acid antagonist |
|---|
| Indication | gastritis |
|---|
| Disease area | gastroenterology |
|---|
All known targets
Mechanisms of action (all sources)
- potassium-competitive acid antagonist
- ATP4A INHIBITOR
- ATP4B INHIBITOR
Cross-references
Synonyms
- revaprazan hydrochloride
- revaprazan HCl
- YH 1885
- revanex
- YH1885
- SB-641257
- YH-1885 FREE BASE
- Revanex
- SB 641257
- 5P184180P5
- REVAPRAZANUM
- RefChem:179017
- Revaprazan [INN]
- UNII-5P184180P5
- MFCD26405757
- REVAPRAZAN [MI]
- REVAPRAZAN [MART.]
- REVAPRAZAN [WHO-DD]
- orb1705501
- SCHEMBL2194461
- SCHEMBL7697657
- SCHEMBL7697658
- SCHEMBL29388090
- C22H23FN4
- GTPL12007
- CHEBI:135529
- LECZXZOBEZITCL-UHFFFAOYSA-N
- GLXC-23919
- EX-A5099
- AKOS040744651
- NCGC00408843-01
- DA-67177
- HY-121851
- CS-0083547
- NS00133763
- G79297
- T20660
- F604331
Look up REVAPRAZAN in the interactive SynDRA portal →